NoxaBH3 is a synthetic peptide that acts as a potent and selective inducer of apoptosis, particularly in cancer cells. It mimics the BH3 domain of the protein Noxa, thereby activating pro-apoptotic signals and promoting programmed cell death. NoxaBH3 has shown potential as a targeted therapy for various cancer types, including colorectal, breast, and lung cancer.
CAT No: GR2224
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More